An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

Source:http://linkedlifedata.com/resource/pubmed/id/18250251

Download in:

View as

General Info

PMID
18250251